Hypertension (Dallas, Tex. : 1979)

Snoring and daytime sleepiness linked to later high blood pressure in a large population study

Updated

Abstract

Among 34,727 participants, the incidence of treated hypertension was 3.8% during a median follow-up of 3.1 years.

  • Self-reported habitual snoring and excessive daytime sleepiness are linked to a higher risk of developing hypertension.
  • Habitual snoring is associated with an adjusted hazard ratio of 1.17 for incident hypertension.
  • Excessive daytime sleepiness has a stronger association, with an adjusted hazard ratio of 1.42 for incident hypertension.
  • The risk of developing hypertension increases with the frequency of snoring and daytime sleepiness, indicating a dose-dependent relationship.
  • These findings suggest that identifying snoring and sleepiness could be beneficial for hypertension prevention strategies.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

All authors have completed the International Committee of Medical Journal Editors uniform disclosure form. P. Balagny reported no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. E. Vidal-Petiot reported honoraria for lectures from Servier and financial support for attending meetings from Servier outside of the submitted work and no other relationships or activities that could appear to have influenced the submitted work. S. Kab reported no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. J. Frija has received unrestricted research grants from LVL medical, payments for lectures from SOS oxygène, support for attending meeting from LVL medical, Vitalaire, ADEP assistance and SOS oxygène, and fiduciary role in Société Française de Recherche et Médecine du Sommeil, and no other relationships or activities that could appear to have influenced the submitted work. P.G. Steg has received grants from Amarin, AstraZeneca, Bayer, Sanofi, and Servier; consulting fees from Amgen, AstraZeneca, Bristol Myers Squibb/Myokarddia, Merck, Novo-Nordisk and Regeneron, Steering Comitee or Critical Event Committee from Amarin, AstraZeneca, Bayer, Boerhriger Ingelheim, Bristo-Myers Squibb, Idorsia, Novartis, PhaseBio, Pfizer, Sanofi, and Servier; payments for lectures from AstraZeneca, Novartis, and Novo-Nordisk; support for attending meetings from AstraZeneca and participation on a Data Safety Monitoring Board or Advisory Board from Servier, Sanofi, Population Health Research Institute and Monash University; and no other relationships or activities that could appear to have influenced the submitted work. M. Goldberg reported no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. M. Zins reported no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. M.P. d’Ortho has received unrestricted research grants from Asten Santé; consultant fees from ResMed; speaker fees from Resmed and LVL; and traveling grants from ADEP Assistance, Vitalaire, and LVL; stock options from Digital Medical Hub Société par Action Simplifiée; and no other relationships or activities that could appear to have influenced the submitted work. E. Wiernik reported no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free